Stockreport

Lilly To Be 'Aggressive' In Migraine Drug — But This Rival Has An Edge [Investor's Business Daily]

ALDER BIOPHARMACEUTICALS INC  (ALDR) 
Last alder biopharmaceuticals inc earnings: 8/6 04:07 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.alderbio.com/node/5806
PDF Related news Eli Lilly ( LLY ) will be "aggressive" in marketing its migraine prevention CGRP antibody, one analyst said Friday, but another says Teva Pharmaceutical ( [Read more]